ENDRA Life Sciences (NDRA) Non Operating Investment Income (2026)
ENDRA Life Sciences' (NDRA) quarterly Non Operating Investment Income came in at $1.3 million in Q2 2026, up 74.88% quarter-over-quarter from $738177.0 in Q1 2026.
Powered by 
Analysis
ENDRA Life Sciences (NDRA) Non Operating Investment Income (2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Non Operating Investment Income for 1 consecutive years, with $1.3 million the latest figure, recorded in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | - |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | -9.54 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | - |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | - |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | - |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | - |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | - |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - | 1.29 Mn |